 "Sun Pharmaceutical")
The country’s largest drug firm Sun Pharma posted a 22 per cent year-on-year (YoY) dip in profit before tax (PBT) for the third quarter of the financial year to Rs 1,351.3 crore while its sales came in at Rs 8,039 crores, growth of 5 per cent over same quarter last year. While the company’s domestic sales posted 13 per cent growth, the US market remained tough, witnessing a fall of 3 per cent YoY.
The net profit for the quarter was Rs 914 crore down 26 per cent YoY due to other expenses, reduction in forex gains and higher taxes, the
